Evidence map›Paper›PMID 30052085›Full record

ArticleExpert review of pharmacoeconomics & outcomes research2018

Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab, Pakistan.

Ali Hassan Gillani, Muhammad Majid Aziz, Imran Masood, Anum Saqib, Caijun Yang, Jie Chang, Mohamed Izham Mohamed Ibrahim, Yu Fang

Registry-linked trialAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Expert review of pharmacoeconomics & outcomes research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06125873 (Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients- an Interventional Study), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06125873 phase2unknown statusstarted 2023, after this paper: background citation

Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients- an Interventional Study

Ran2023Enrolled50Registered outcomes5Posted comparisons0ConditionsDiabetes Mellitus Type 2ArmsMetformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.Diabetes, metabolic syndrome and obesity : targets and therapy · 2024
    Review
  9. Article
  10. Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings from a Lower-Middle Income Country.International journal of environmental research and public health · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ali Hassan Gillania Department of Pharmacy Administration and Clinical Pharmacy , School of pharmacy Xi'an Jiaotong University , Xi'an , China.
Muhammad Majid Aziza Department of Pharmacy Administration and Clinical Pharmacy , School of pharmacy Xi'an Jiaotong University , Xi'an , China.
Imran Masoode Department of Pharmacy , Islamia University of Bahawalpur , Punjab , Pakistan.
Anum Saqibe Department of Pharmacy , Islamia University of Bahawalpur , Punjab , Pakistan.
Caijun Yanga Department of Pharmacy Administration and Clinical Pharmacy , School of pharmacy Xi'an Jiaotong University , Xi'an , China.
Jie Changa Department of Pharmacy Administration and Clinical Pharmacy , School of pharmacy Xi'an Jiaotong University , Xi'an , China.
Mohamed Izham Mohamed Ibrahimf Department of Social & Administrative Pharmacy, Clinical Pharmacy and Practice Section , College of Pharmacy Qatar University , Doha , Qatar.
Yu Fanga Department of Pharmacy Administration and Clinical Pharmacy , School of pharmacy Xi'an Jiaotong University , Xi'an , China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiabetes mellitus (DM) has a very high prevalence and poses a huge financial encumbrance on patients. This study aimed to evaluate the cost of diabetes care among patients with type 2 diabetes in private clinics of southern Punjab, Pakistan. RESEARCH DESIGN AND

methodsThis was a descriptive, cross-sectional, prevalence-based, cost-of-illness (COI) study conducted in six private clinics of southern Punjab from July to September 2016, using a pretested questionnaire. Study participants were recruited using a random selection method. Continuous variables, including direct and indirect costs, were summarized using descriptive statistics. Inferential statistics were also used to analyze the correlation between the variables and cost.

resultsThe mean annual direct cost per patient with diabetes was estimated to be 332 USD. Medications accounted for the largest share (60.4%) of this cost. Age, locality, high socioeconomic status, and prolonged disease duration were significantly associated with the direct costs of illness (p < 0.05). Moreover, 19% of total earnings among very low-income patients were spent on diabetes care.

conclusionsA substantial proportion of patients' income is spent on diabetes care in Punjab. Our findings support the substantial individual and societal burden caused by diabetes.

Indexed as

Cost of IllnessHealth Care CostsAdolescentAdultAge FactorsCross-Sectional StudiesDiabetes Mellitus, Type 2Drug CostsFemaleHumansHypoglycemic AgentsIncomeMaleMiddle AgedPakistanPrevalenceHypoglycemic AgentsDiabetes mellitusdirect cost on diabetesindirect costPakistan

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.